TYBR Health reports first clinical use of tissue protector in US

The B3 GEL System maintains biomechanical separation throughout the essential healing window.

TYBR Health has announced the first US clinical use of the collagen-based tissue protector, B3 GEL System, aimed at supporting post-surgical healing.

The flowable gel system’s clinical use was initiated by Dr Hanna Tammam, a fellowship-trained hand, elbow, and shoulder surgeon based in Lubbock, Texas.

The B3 GEL System is derived from the extracellular matrix (ECM). Unlike conventional physical barriers that may be challenging to position within tight anatomical areas, it offers a flowable format that conforms to tissue surfaces.

Sign up for Blog Updates